| # | Drug | Count |
|---|---|---|
| 0 | BLEOMYCIN SULFATE | 44 |
| 1 | DOXORUBICIN | 42 |
| 2 | BLEOMYCIN | 39 |
| 3 | ETOPOSIDE | 38 |
| 4 | CYCLOPHOSPHAMIDE | 37 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 37 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 37 |
| 7 | FINASTERIDE | 32 |
| 8 | PREDNISONE | 24 |
| 9 | IFOSFAMIDE FOR INJECTION | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINBLASTINE SULFATE | 16 | 0.0082 |
| 1 | BLEOMYCIN SULFATE | 44 | 0.0042 |
| 2 | DEXRAZOXANE FOR INJECTION | 3 | 0.0032 |
| 3 | CARMUSTINE | 13 | 0.0028 |
| 4 | AMOXAPINE | 1 | 0.0021 |
| 5 | TESTOSTERONE UNDECANOATE | 3 | 0.0015 |
| 6 | IFOSFAMIDE FOR INJECTION | 23 | 0.0011 |
| 7 | DACARBAZINE | 7 | 0.0009 |
| 8 | ILOPERIDONE | 1 | 0.0007 |
| 9 | VINORELBINE | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 65 |
| 1 | Corticosteroid [EPC] | 57 |
| 2 | Topoisomerase Inhibitor [EPC] | 38 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 33 |
| 4 | Platinum-based Drug [EPC] | 28 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 7 | Atypical Antipsychotic [EPC] | 18 |
| 8 | Androgen [EPC] | 13 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 1 | Topoisomerase Inhibitor [EPC] | 38 | 0.0005 |
| 2 | Androgen [EPC] | 13 | 0.0005 |
| 3 | Gonadotropin [EPC] | 1 | 0.0005 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 33 | 0.0003 |
| 6 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 8 | Alkylating Drug [EPC] | 65 | 0.0003 |
| 9 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |